HIV and bacterial sexually transmitted infections (STIs), including syphilis, *Neisseria gonorrhea* (NG), and *Chlamydia trachomatis* (CT), remain a significant public health problem in the United States, and men who have sex with men (MSM) continue to be disproportionately affected by these infectious diseases \[[@CIT0001], [@CIT0002]\]. An estimated 15% of individuals living with HIV are unaware of their diagnosis \[[@CIT0003]\]. The diagnosis of an STI is a well-established risk factor for HIV acquisition \[[@CIT0004]\]. In recognition of the key preventive role played by routine testing, the US Centers for Disease Control and Prevention (CDC) recommends at least annual HIV and STI screening in all sexually active MSM, with more frequent testing for individuals who engage in high-risk behavior \[[@CIT0005], [@CIT0006]\]. Despite these recommendations, rates of testing remain below recommended levels in the United States \[[@CIT0007], [@CIT0008]\].

A wealth of data supports the feasibility and acceptability of self-administered HIV and STI sample collection and testing \[[@CIT0009], [@CIT0010]\]. Advances in molecular diagnostics have made rapid self-testing increasingly feasible and affordable, and improved global access to digital technology has allowed for improved access to testing services. Utilizing these advances, novel HIV/STI testing programs promoting the use of rapid self-testing outside the traditional clinic setting have shown increased uptake of testing, decreased time to testing, and increased diagnosis of early infection \[[@CIT0011]\]. However, other studies have failed to demonstrate these benefits \[[@CIT0016]\]. Considerable heterogeneity exists between the structural elements of these programs, including the type of rapid HIV test utilized (oral, dried blood spot, minitube) \[[@CIT0011], [@CIT0015], [@CIT0016]\], the venue at which HIV/STI rapid self-testing is available for use (walk-in clinic, home) \[[@CIT0013], [@CIT0014]\], and test result delivery (electronically via secure website, provider phone call, text message) \[[@CIT0011], [@CIT0012], [@CIT0015]\], which may explain the differences seen in program uptake. Although the CDC now supports the incorporation of HIV self-testing into large-scale testing programs \[[@CIT0017]\], further investigation of the optimal utilization of the elements of self-testing programs is needed.

METHODS {#s1}
=======

We performed a cross-sectional study of a convenience sample of MSM in San Diego, California, to improve our understanding of prevailing attitudes and preferences regarding commercially available rapid HIV and 3-site GC/CT testing methods and perceived barriers to routine HIV/STI testing in order to optimize an existing community-based testing program targeting MSM and guide future program expansion efforts to promote uptake among high-risk individuals. Men at least 18 years of age who were sexually active in the past 3 months with at least 1 male sexual partner were invited to complete an anonymous online survey (SurveyMonkey) at a community-based HIV/STI screening program from October through December of 2014 via an advertising banner on their electronic and paper HIV/STI test result sheets. Upon completion of the survey, respondents received a link to a \$5 electronic gift card. Respondents were not required to answer all questions in order to complete the survey. Participation was anonymous, and no personal identifying information was collected. Survey questions collecting demographic information, risk behaviors in the past 12 months, HIV/STI testing history, and barriers to HIV/STI testing were adapted from a previously published CDC HIV testing perspectives survey tool \[[@CIT0018]\]. Respondents were asked to select any of the listed reasons that had ever prevented them from testing, and multiple responses were allowed. Respondents were categorized as engaging in high-risk behavior if they reported 2 or more of the following behaviors: unprotected anal intercourse in the last 3 months, more than 5 sex partners in the past 12 months, sex in exchange for money or drugs in the past 12 months, self-reported STI diagnosis or sexual activity under the influence of recreational drugs/alcohol in the past 12 months. Respondents who reported that they had engaged in none or only 1 of these behaviors were categorized as low risk. Respondents were then asked to give their opinion regarding multiple components of a hypothetical HIV/STI testing program. Questions pertaining to HIV and STI were asked separately. Only HIV-negative respondents were asked to provide HIV testing preferences. Respondents were instructed to assume that the services in this hypothetical testing program would be free of charge. The hypothetical testing program components included commercially available tests for HIV (rapid oral swab, rapid dried blood spot, traditional blood draw) and STI (self- or provider-collected urine and oral/rectal swabs for NG/CT), locations where HIV/STI testing could be obtained and performed (home, traditional clinic setting, community outreach event or mobile testing van, electronic kiosk at a public location such as a bar or bathhouse), and test result delivery methods (login to a secure website, unsecure e-mail or text message, health provider phone call or clinic visit, letter in the mail). Respondents were then asked to directly rank their preferred test type, venue, and result delivery method. The study protocol and all study-related procedures were approved by the UCSD Human Research Protections Program, including a waiver of consent.

The primary outcome was test venue preference. Secondary outcomes included test type preference, specimen collection technique preference, test result delivery preferences, perceived barriers to testing, and appropriateness of testing interval based on risk group, as defined by the current CDC guidelines for HIV and STI testing for sexually active MSM \[[@CIT0005], [@CIT0006]\]. Primary and secondary outcomes were compared between HIV serostatus, age, and risk groups using the Fisher exact test at an alpha level of 0.05. Statistical analysis was performed with SPSS, version 24 (SPSS Inc., Chicago, IL).

RESULTS {#s2}
=======

Of the 137 surveys completed, 28 were excluded ([Figure 1](#F1){ref-type="fig"}). The baseline characteristics of the 109 MSM included in the final analysis are shown in [Table 1](#T1){ref-type="table"}. Seventy-six respondents (69.7%) were classified as high risk. Eighty-eight respondents (80.7%) reported a negative HIV serostatus at the time of most recent testing and were included in the analysis of HIV testing preferences. All respondents who provided responses were included in the analysis of STI testing preferences and perceived HIV/STI testing barriers.

###### 

Demographic and Behavioral Risk Characteristics

  Characteristic                                   All Participants (n = 109), No. (%)
  ------------------------------------------------ -------------------------------------
  Race                                             
   White                                           81 (74.3)
   Black                                           8 (7.3)
   Hispanic                                        14 (12.8)
   Other                                           6 (5.5)
  Age                                              
   ≤45 y                                           76 (69.7)
   ≥46 y                                           33 (30.3)
  Education                                        
   GED/HS diploma only                             82 (75.2)
   Bachelor's degree or higher                     27 (24.8)
  Income                                           
   \<\$20 000                                      15 (13.8)
   \$20 000--\$60 000                              39 (35.8)
   \>\$60 000                                      55 (50.5)
  Risk group                                       
   MSM                                             109 (100)
   MSM + IDU                                       3 (2.8)
  Risk behaviors                                   
   Unprotected sex                                 92 (84.4)
   \>5 partners in past 12 mo                      70 (64.2)
   Sex work                                        4 (3.7)
   Self-reported STI in past 12 mo                 33 (30.3)
   Use of drugs or alcohol during sex              36 (33.0)
   None (none of the above risk factors)           28 (25.7)
  Overall risk behavior profile                    
   High risk (any 2 of the above risk behaviors)   76 (69.7)

Abbreviations: GED, General Education Development certificate; HS, high school; IDU, injection drug user; MSM, men who have sex with men; STI, sexually transmitted infection.

![Survey response and exclusion.](ofz043f0001){#F1}

Preference for HIV test type, test location, and result delivery are presented in [Table 2](#T2){ref-type="table"}. The preferred test type was a rapid oral HIV test (71.1%), and the preferred venue for use of rapid HIV testing was home (78.5%). Respondents preferred to receive negative HIV test results electronically via secure website or text/e-mail (76.4%). However, respondents preferred to receive positive HIV test results directly from a provider, either by phone or an in-person clinic visit (70%). Nearly all respondents (94%) indicated that they would be comfortable making their own follow-up arrangements upon receipt of a positive result outside of a clinic setting. There were no significant differences in HIV testing preferences between age groups or risk behavior groups.

###### 

HIV and STI Testing and Result Notification Preferences

  Preference                                      All Participants, No. (%)   Age ≤45 y, No. (%)   Age ≥46 y, No. (%)   *P* Value
  ----------------------------------------------- --------------------------- -------------------- -------------------- -----------
  HIV test type                                   n = 83                      n = 64               n = 19               
   Rapid oral                                     59 (71.1)                   45 (70.3)            14 (73.7)            1.00
   Rapid finger stick                             7 (8.4)                     7 (10.9)             0 (0)                .34
   Traditional clinic test                        17 (20.5)                   12 (18.8)            5 (26.3)             .52
  Rapid HIV test location                         n = 79                      n = 59               n = 20               
   Home                                           62 (78.5)                   47 (79.7)            15 (75.0)            .76
   Clinic                                         12 (15.2)                   9 (15.3)             3 (15.0)             1.00
   Community health                               5 (6.3)                     3 (5.1)              2 (10.0)             .60
   Retail                                         0 (0)                       0 (0)                0 (0)                n/a
   Social venue                                   0 (0)                       0 (0)                0 (0)                n/a
  HIV test result notification: negative result   n = 72                      n = 53               n = 19               
   Electronic: secure website login               24 (33.3)                   17 (32.1)            7 (36.8)             .78
   Electronic: e-mail or text message             31 (43.1)                   22 (41.5)            9 (47.4)             .79
   Health provider call or office visit           17 (23.6)                   14 (26.4)            3 (15.8)             .53
   US mail                                        0 (0)                       0 (0)                0 (0)                n/a
  HIV test result notification: positive result   n = 72                      n = 53               n = 19               
   Electronic: secure website login               10 (13.9)                   7 (13.2)             3 (15.8)             .72
   Electronic: e-mail or text message             10 (13.9)                   9 (17.0)             1 (5.3)              .27
   Health provider call or office visit           52 (72.2)                   37 (69.8)            15 (78.9)            .56
   US mail                                        0 (0)                       0 (0)                0 (0)                n/a
  Rapid STI test collection method/location       n = 82                      n = 55               n = 27               
   Collect own samples at home                    50 (61.0)                   29 (52.7)            21 (77.8)            .03\*
   Collect own samples at clinic                  10 (12.2)                   8 (14.5)             2 (7.4)              .49
   Health professional collect in clinic          22 (26.8)                   18 (32.7)            4 (14.8)             .11
  STI test result notification: negative result   n = 76                      n = 51               n = 25               
   Electronic: secure website login               23 (30.3)                   15 (29.4)            8 (32.0)             1.00
   Electronic: e-mail or text message             35 (46.1)                   23 (45.1)            12 (48.0)            1.00
   Health provider call or office visit           18 (23.7)                   13 (25.5)            5 (20.0)             .78
   US mail                                        0 (0)                       0 (0)                0 (0)                n/a
  STI test result notification: positive result   n = 76                      n = 51               n = 25               
   Electronic: secure website login               13 (17.1)                   7 (13.7)             6 (24.0)             .33
   Electronic: e-mail or text message             19 (25.0)                   12 (23.5)            7 (28.0)             .78
   Health provider call or office visit           43 (56.6)                   32 (62.7)            11 (44.0)            .15
   US mail                                        1 (1.3)                     0 (0)                1 (4.0)              .33

Abbreviation: STI, sexually transmitted infection.

\**P* \< .05.

Preference for STI test type, test location, and result delivery are presented in [Table 2](#T2){ref-type="table"}. The preferred test type was self-collection (73.2%), and the preferred venue for specimen self-collection was home (61%). Respondents age \>45 years were more likely to prefer home STI specimen collection (77.8% vs 52.7%, *P* = .033). Respondents preferred to receive negative STI test results electronically via secure website or text/e-mail (76.4%). However, respondents preferred to receive positive STI test results directly from a provider, either by phone or an in-person clinic visit (56.6%). Nearly all respondents (97%) indicated that they would be comfortable making their own follow-up arrangements upon receipt of a positive result outside of a clinic setting. There were no significant differences in STI testing and results delivery preferences between serostatus or risk behavior groups.

Perceived barriers to HIV testing are presented in [Table 3](#T3){ref-type="table"}. The most frequently reported reasons for not receiving HIV testing were a lack of known prior HIV exposure (57.3%), fear/anxiety (45.3%), and inconvenience (40.0%). Respondents age \<45 years were significantly more likely to report inconvenience as a barrier to testing (50.9% vs 17.4%, *P* = .010). HIV-positive respondents were less likely to report lack of known prior HIV exposure than HIV-negative respondents (25.0% vs 62.9%, *P* = .028). There were no differences between risk behavior groups.

###### 

Reported Barriers to HIV and STI Testing

  Testing Barriers       All Participants, No. (%)   Age Category                       Risk Category                       HIV Serostatus              
  ---------------------- --------------------------- -------------- ----------- ------- --------------- ----------- ------- ---------------- ---------- -------
  HIV testing barriers   n = 75                      n = 52         n = 23              n = 25          n = 50              n = 62           n = 12     
   No exposure           43 (57.3)                   26 (50.0)      17 (73.9)   .08     16 (64.0)       27 (54.0)   .47     39 (62.9)        3 (25.0)   .02\*
   Fear/anxiety          34 (45.3)                   25 (48.1)      9 (39.1)    .62     8 (32.0)        26 (52.0)   .14     25 (40.3)        9 (75.0)   .05
   Privacy concerns      8 (10.7)                    6 (11.5)       2 (8.7)     1.00    2 (8.3)         6 (12.0)    .71     8 (12.9)         0 (0)      .34
   Fear of needles       2 (2.7)                     2 (3.8)        0 (0)       1.00    1 (4.0)         1 (2.0)     1.00    2 (3.2)          0 (0)      1.00
   Lack of venue         7 (9.3)                     6 (11.5)       1 (4.3)     .43     2 (8.0)         5 (10.0)    1.00    6 (9.7)          0 (0)      .58
   Cost                  2 (2.7)                     2 (3.8)        0 (0)       1.00    1 (4.0)         1 (2.0)     1.00    2 (3.2)          0 (0)      1.00
   Inconvenience         30 (40.0)                   27 (50.9)      4 (17.4)    .01\*   8 (32.0)        22 (44.0)   .45     26 (41.9)        3 (25)     .35
  STI testing barriers   n = 70                      n = 48         n = 22              n = 19          n = 51              n = 57           n = 13     
   No exposure           44 (62.9)                   28 (58.3)      16(72.7)    .30     16 (84.2)       28 (54.9)   .03\*   39 (68.4)        5 (38.5)   .06
   No symptoms           41 (58.6)                   28 (58.3)      13 (59.1)   1.00    8 (42.1)        33 (64.7)   .11     33 (57.9)        8 (61.5)   1.00
   Fear/anxiety          15 (21.4)                   13 (27.1)      2 (9.1)     .12     2 (10.5)        13 (25.5)   .21     11 (19.3)        4 (30.8)   .46
   Privacy concerns      11 (15.7)                   6 (12.5)       5 (22.7)    .30     2 (10.5)        9 (17.6)    .72     6 (10.5)         5 (38.5)   .03\*
   Fear of needles       3 (4.3)                     2 (4.2)        1 (4.5)     1.00    1 (5.3)         2 (3.9)     1.00    3 (5.3)          0 (0)      1.00
   No venue              7 (10.0)                    6 (12.5)       1 (4.5)     .42     0 (0)           7 (13.7)    .18     7 (12.3)         0 (0)      .33
   Cost                  3 (4.3)                     3 (6.3)        0 (0)       .55     1 (5.3)         2 (3.9)     1.00    3 (5.3)          0 (0)      1.00
   Inconvenience         35 (50.0)                   28 (58.3)      7 (31.8)    .07     6 (31.6)        29 (56.9)   .11     28 (49.1)        7 (53.8)   1.00

Participants were asked to choose all that applied; percentages do not sum to 100.

Abbreviation: STI, sexually transmitted infection.

\**P* \< .05.

Perceived barriers to STI testing are presented in [Table 3](#T3){ref-type="table"}. The most frequently reported reasons for not receiving STI testing were lack of known prior STI exposure (62.9%), absence of STI symptoms (58.6%), and inconvenience (50%). Respondents age \<45 years more frequently cited inconvenience as a barrier to testing, though this difference did not meet statistical significance (58.3% vs 31.8%, *P* = .070). Respondents engaged in high-risk behavior were significantly less likely to report lack of known prior STI exposure than those with lower-risk behavior (54.9% vs 84.2%, *P* = .028). HIV-positive respondents were more likely to report privacy concerns as a barrier to STI testing than HIV-negative respondents (30.8% vs 10.5%, *P* = .025).

An evaluation of HIV testing history among HIV-negative respondents is presented in [Table 4](#T4){ref-type="table"}. Sixty-five respondents reported prior HIV testing within the past 3 months (73%), with an additional 16 respondents reporting prior HIV testing within the past year (18%). High-risk respondents were significantly more likely to have reported testing in the past 3 months (85.0% vs 53.8%, *P* = .001). Lower-risk respondents were significantly more likely to have reported testing in the past 4--12 months (42.3% vs 8.3%, *P* \< .001).

###### 

HIV Testing History

  Testing History        All HIV-, No. (%)   Lower-Risk Behavior   High-Risk Behavior   *P* Value
  ---------------------- ------------------- --------------------- -------------------- -----------
  Prior HIV test         n = 88              n = 27                n = 61               .30
   Yes                   87 (98.9)           26 (96.3)             61 (100)             
   No                    1 (1.1)             1 (3.7)               0 (0)                
  Most recent HIV test   n = 86              n = 26                n = 60               
   Tested \>12 mo ago    5 (5.6)             1 (3.8)               4 (6.5)              1.00
   Tested 4--12 mo ago   16 (18.0)           11 (42.3)             5 (8.3)              \<.001\*
   Tested 1--3 mo ago    65 (73)             14 (53.8)             51 (85.0)            .005\*

\**P* \< .05.

DISCUSSION {#s3}
==========

Respondents expressed a strong preference for the use of a rapid oral test for HIV testing and self-collection of specimens for STI testing in the home. Given the wide variety of feasible alternative HIV testing venues that have been described, including community outreach events/mobile testing programs and kiosks located in public spaces (bar or bathhouse) \[[@CIT0019]\], the major strength of this study was the ability of respondents to directly rank these options against the option of home testing. A single study demonstrating a preference for HIV home testing among MSM allowed respondents to directly rank their preferred testing venue but restricted respondents' options to home- and clinic-based testing \[[@CIT0023]\]. Yang and colleagues also demonstrated a preference for home HIV testing among Australian MSM when allowed to choose between testing at home, at a community-based organization, and at a clinic, though participants only appear to have been given the option to choose their most preferred venue rather than rank all options \[[@CIT0024]\]. As there are currently no commercially available rapid home STI tests in the United States, the only hypothetical alternative STI testing venue described in this survey was the home. A single study demonstrating a preference for home STI testing among MSM also limited testing venue options to home- and clinic-based testing but did not present the option of specimen self-collection in the clinic \[[@CIT0025]\]. A further strength of this study is the stratification of preference by age and risk behavior, which was not performed in the aforementioned studies. Interestingly, respondents age \<45 years were somewhat less likely to prefer home specimen collection for STI but did not prefer it for HIV testing. As any STI testing specimens collected at home would require some form of specimen transport to a lab, either via mail or physical dropoff, it is conceivable that young respondents who do not yet live independently or have private transportation may have reasonable privacy concerns related to rapid home STI but not HIV testing.

Our study also evaluated perceived barriers that may limit routine HIV and STI testing. Although nearly 70% of respondents reported engaging in high-risk behaviors, a lack of known prior HIV/STI exposure was the most frequently reported reason for not obtaining both routine HIV and STI testing. Despite longstanding and widespread educational efforts, MSM populations frequently report a lower perceived risk of HIV/STI infection than their self-reported behaviors would indicate \[[@CIT0026]\]. However, high-risk respondents were significantly more likely to have reported HIV testing in the past 3 months and significantly less likely to report lack of known prior STI exposure as a barrier to STI testing. Furthermore, HIV-positive individuals were less likely to report lack of known prior HIV exposure as a prior barrier to HIV testing. These findings would seem to indicate a general awareness of risk status in this cohort, despite their reported barriers. Recent studies have demonstrated an association between receiving multiple negative HIV tests and increased high-risk sexual behavior among MSM \[[@CIT0027], [@CIT0028]\]. Mustanski and colleagues developed the Inventory of Reactions to Testing HIV Negative (IRTHN) to better quantify diverse reactions to testing negative for HIV, and the initial evaluation revealed that individuals who expressed the belief that a negative HIV test was due to either chance (Luck reaction) or immunity from becoming infected with HIV (Invulnerability reaction) were more likely to be engaged in high-risk sexual behavior \[[@CIT0029]\]. In a subsequent validation of this tool, Feinstein and colleagues replicated the findings of Mustanski et al. and found an association between the belief that a negative HIV test result represented the acceptability of condomless sex (Reinforced Risk reaction) and increased high-risk sexual behavior \[[@CIT0030]\]. Significantly, Feinstein and colleagues also found that lower levels of HIV knowledge, motivation to reduce risk behavior, and behavioral skills to engage in preventive behavior were associated with both the Invulnerability and Reinforced Risk reactions \[[@CIT0030]\]. In addition, although it has become increasingly recognized that the majority of STI infections, particularly at extragenital sites in MSM, are asymptomatic \[[@CIT0031]\], and despite the relatively high socioeconomic status and education level in our cohort, more than half of respondents reported a lack of STI symptoms as a reason for not obtaining routine testing. These results highlight the need for further educational outreach initiatives targeting both HIV knowledge and beliefs regarding the significance of HIV test results in the MSM population.

Inconvenience was cited by many respondents, particularly young individuals, as a barrier to both HIV and STI testing, suggesting that currently utilized testing strategies are not perceived as convenient. Prior research has suggested that the perception of convenience influences the decision to test \[[@CIT0032], [@CIT0033]\]. Recognition of the increasing importance of convenience in modern health care delivery is reflected in the CDC recommendation to integrate universal HIV screening into routine medical care. As qualitative assessments have revealed that self-testing is perceived as a way to avoid multiple time-consuming clinic visits and make testing more accessible \[[@CIT0024], [@CIT0034]\], the prioritized integration of home rapid HIV and STI testing options into large-scale testing programs has the potential to address this barrier, particularly among young MSM who are at the greatest risk for acquiring HIV and STIs \[[@CIT0001], [@CIT0002]\].

Result delivery is another aspect of the testing process that affects convenience. Our study respondents expressed a preference for electronic delivery of negative STI and HIV results, which has been reported in prior studies \[[@CIT0035], [@CIT0036]\]. With growing access worldwide to electronic communication and social media, this preference will likely continue to increase. A quantitative and qualitative analysis of factors influencing the willingness and barriers to self-HIV testing in MSM in the United Kingdom performed by Flowers and colleagues suggested that rapid test use and acceptability correlated with increasing digital literacy \[[@CIT0037]\]. However, it is important to consider the disadvantages of electronic result notification. Electronic result delivery eliminates health care provider contact, which may deprive an individual of the opportunity to obtain timely and accurate education regarding specific disease symptoms, risk behavior reduction, prevention counseling, and partner notification, which is also reflected in the respondents' preference for direct provider interaction for delivery of a positive HIV or STI test result. Given the previously noted persistence of high-risk behavior and misinformation regarding the significance of lack of STI symptoms in this cohort, large-scale HIV/STI testing programs should seek to design their programs to balance convenience with the need for continued educational outreach efforts.

In contrast to prior studies \[[@CIT0038], [@CIT0039]\], only a minority of participants reported privacy concerns as a barrier to HIV and STI testing, though this was more frequently cited among HIV-positive respondents. Multiple recent studies have demonstrated that home-based HIV and STI testing is perceived as more private than traditional clinic-based testing \[[@CIT0037], [@CIT0040]\]. Efforts to decrease the stigma of HIV and STI, advances in HIV treatment, and increasing acceptance and use of social media and other less secure communication platforms have likely contributed to this trend. As our population was comprised of mostly frequent testers currently utilizing a traditional clinic testing venue, the overall high comfort level with current privacy protections seen in this cohort may not be generalizable to other MSM communities, particularly those who are less frequent testers. Investigation of perceptions regarding the impact of the level of privacy of various result delivery mechanisms on the uptake of self-testing programs remains an area for further research.

This study was subject to several limitations. Although we attempted to robustly describe each of the potential options for test type, venue, and result delivery system, the online survey format did not allow respondents to ask clarifying questions, which may have impacted their reported preferences. Self-reported risk behaviors and subsequent risk stratification were also subject to nonresponse bias due to the survey format. The sample size was relatively small, with only 109 respondents completing the demographic information section and fewer respondents completing all sections of the survey. Completion of the survey required Internet access and was time-consuming, typically requiring 30 minutes to complete, which likely limited participation and thus the generalizability of the results. The population reached by this survey was relatively homogenous and may not be reflective of MSM communities in other geographic regions. Finally, the data set was collected in 2014, and behaviors and/or preferences may have changed since then.

CONCLUSIONS {#s4}
===========

Rapid HIV and STI tests for home use are preferred over multiple other potential alternative test venues in San Diego MSM. Although additional research is needed to identify the optimal utilization of multiple aspects of a large-scale HIV and STI self-testing program, increasing resources directed specifically toward home testing has the potential to translate into improved uptake of rapid HIV and STI testing, particularly by reducing inconvenience in the testing process. However, efforts to improve convenience in testing programs should be carefully balanced with the need for continued educational outreach efforts.
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